Utility of Immunophenotypic Measurable Residual Disease in Adult Acute Myeloid Leukemia—Real-World Context

Introduction: One of the mainstays of chemotherapy in acute myeloid leukemia (AML) is induction with a goal to achieve morphological complete remission (CR). However, not all patients by this remission criterion achieve long-term remission and a subset relapse. This relapse is explained by the prese...

Descripción completa

Detalles Bibliográficos
Autores principales: Patkar, Nikhil, Kakirde, Chinmayee, Bhanshe, Prasanna, Joshi, Swapnali, Chaudhary, Shruti, Badrinath, Yajamanam, Ghoghale, Sitaram, Deshpande, Nilesh, Kadechkar, Shraddha, Chatterjee, Gaurav, Kannan, Sadhana, Shetty, Dhanalaxmi, Gokarn, Anant, Punatkar, Sachin, Bonda, Avinash, Nayak, Lingaraj, Jain, Hasmukh, Bagal, Bhausaheb, Menon, Hari, Sengar, Manju, Khizer, Syed Hasan, Khattry, Navin, Tembhare, Prashant, Gujral, Sumeet, Subramanian, Papagudi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584962/
https://www.ncbi.nlm.nih.gov/pubmed/31263671
http://dx.doi.org/10.3389/fonc.2019.00450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584962/
https://www.ncbi.nlm.nih.gov/pubmed/31263671
http://dx.doi.org/10.3389/fonc.2019.00450

Ejemplares similares